9 farmaci in commercio

Italia

Nuove specialitÓ medicinali:Maalox, Opdivo, Trisenox.6 nuovi farmaci equivalenti

Nuove specialità medicinali
MAALOX 30 cpr masticabili 400 mg + 400 mg magnesio idrossido/algeldrato
SANOFI AIC:020702294 - C/OTC in commercio dal:19/03/2020

OPDIVO 1 flaconcino 24 ml 10 mg/ml nivolumab
BRISTOL AIC:044291033 5.324,22€ H/OSP in commercio dal:02/04/2020

TRISENOX EV 10 flaconcini 6 ml 2 mg/ml arsenico triossido
TEVA AIC:035712025 5.634,96€ H/OSP in commercio dal:17/03/2020

Nuovi farmaci equivalenti
DULOXETINA MYLAN 28 cps gastrores 60 mg duloxetina cloridrato
MYLAN AIC:044267502 16,51€ A/RR in commercio dal:17/03/2020

ILOPROST TEVA 1 fiala 50 mcg/0,5 ml iloprost sale di trometamolo
TEVA AIC:047496017 157,04€ Cnn/OSP in commercio dal:20/03/2020

LIDOCAINA KABI 20 fiale 10 ml 200 mg lidocaina cloridrato
FRESENIUS KABI AIC:046867089 252,22€ C/RNR in commercio dal:16/03/2020

PARACETAMOLO MARCO VITI 1 flaconcino gtt 30 ml paracetamolo
MARCO VITI AIC:039895040 - C/ SOP in commercio dal:16/03/2020

SILODOSINA AUROBINDO 30 cps 8 mg silodosina
AUROBINDO AIC:047984113 7,32€ A/RR in commercio dal:21/03/2020

SUMATRIPTAN AUROBINDO ITALIA 4 cpr 50 mg sumatriptan succinato
AUROBINDO AIC:046202014 6,00€ A/RR in commercio dal:20/03/2020